2026
article
OpenAlex
Abdelrahman Hafez, Ahmed K. Mahmoud, Kamal Awad, Mohamed Reyad Mohamed et autres
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Ahmed W. Hageen, Ahmed Farid Gadelmawla, Ahmad Omar Saleh, Mohamed Reyad Mohamed et autres
BACKGROUND AND AIM: Orforglipron (OFG), an oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RAs), showed potential benefits for type 2 diabetes mellitus (T2DM) and obesity. Its dose-response effects on body weight-related parameters and glycemic outcomes remain incompletely analysed. This network meta-analysis aims …
Égypte, jo, us, sy
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Ahmed W. Hageen, Ahmed Farid Gadelmawla, Ahmad Omar Saleh, Abdallfatah Abdallfatah et autres
BACKGROUND AND AIM: Orforglipron (OFG), an oral small-molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA), has demonstrated significant weight loss and glycemic benefits in adults with or without type 2 diabetes (T2DM). However, its gastrointestinal (GI), hepatic and pancreatic safety profile has not …
Égypte, jo, us, sy, Éthiopie
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Mazhar Ali shah, FNU Sawaira, Ahmed W. Hageen, M Rafiqul Islam et autres
Égypte
(code pays fourni par la source)
Accès ouvert
2025
review
OpenAlex
Abdelrahman Hafez, Ahmed Abdelaziz, Ahmed Mansour, Ali Bakr et autres
Background/Objectives: Esaxerenone, a novel non-steroidal mineralocorticoid receptor antagonist, has shown promising results in the treatment of essential hypertension (HTN). This study aims to comprehensively analyze the effectiveness of esaxerenone to control BP in patients with essential HTN. Methods: A systematic search was …
us, Égypte
(code pays fourni par la source)
Accès ouvert
2023
review
OpenAlex
Noran Magdy Shalma, Hazem Mohamed Salamah, Ashraf Alsawareah, Ahmad Shehata Shaarawy et autres
BACKGROUND: Platelet-rich plasma (PRP) is an autologous platelet concentration recently used in the reproductive field. Studies had conflicting results regarding its effect on pregnancy outcomes. We aimed to solve the debate on the safety and efficacy of PRP in women undergoing assisted …
Égypte, jo, Rwanda
(code pays fourni par la source)